TiffanyY.SiaMD

Gynecologic Oncology

Fellow in Training

Dr. Sia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

New York Presbyterian Hospital (Columbia Campus)Residency, Obstetrics and Gynecology, 2017 - 2021
Columbia University Vagelos College of Physicians and SurgeonsClass of 2017
Memorial Sloan Kettering Cancer CenterFellowship, Gynecologic Oncology

Outstanding Resident in Gynecologic Oncology The Society of Gynecologic Oncology, 2021
Recognition of Excellence in Minimally Invasive Gynecology AAGL, 2020

PubMed

11 citations
Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series.
Tiffany Y Sia, Beryl Manning-Geist, Sushmita Gordhandas, Rajmohan Murali, Antonio Marra
International Journal of Gynecological Cancer. 2022-08-01
3 citations
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Ke...
Tiffany Y Sia, Beryl L Manning-Geist, Sarah Ehmann, Jessica A Lavery, Carrie Luardo
Gynecologic Oncology. 2023-09-01
2 citations
Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake.
Maureen Byrne, Tiffany Y Sia, Christopher Fong, Aliya Khurram, Michele Waters
Gynecologic Oncology. 2024-04-01

Journal Articles

Electrosurgical hysteroscopy: Principles and expert techniques for optimizing the resectoscope loop
Tiffany Y. Sia, Hye-Chun Hur, OBG Management, 8/1/2021
Laparoscopic specimen retrieval bags in gyn surgery: Expert guidance on selection
Tiffany Sia, Hye-Chun Hur, OBG Management, 10/2020

Frailty Screening Should Be Routine in Endometrial Cancer SurgeryApril 2nd, 2021
Tiffany Sia, MD, Provides Rationale for Exploring Interventions for Oligoprogressive Disease in Gynecologic Malignancies Treated With ICIOctober 3rd, 2022